Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension.

S Papapoulos; Z Man; D Mellstrom; S Radominski; J-Y Reginster; H Resch; J Roman; S Roux; S Cummings; H Bone; R Chapurlar; M Brandi; J Brown; E Czerwinski; N Daizadeh; A Grauer; M-A Krieg; S Libanati

doi:10.14341/osteo2011140-40

Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension.

S Papapoulos, Z Man, D Mellstrom, S Radominski, J-Y Reginster, H Resch, J Roman, S Roux, S Cummings, H Bone, R Chapurlar, M Brandi, J Brown, E Czerwinski, N Daizadeh, A Grauer, M-A Krieg, S Libanati

https://doi.org/10.14341/osteo2011140-40

Full Text:

PDF (Rus)

Generate QR code

About the Authors

S Papapoulos

Z Man

D Mellstrom

S Radominski

J-Y Reginster

H Resch

J Roman

S Roux

S Cummings

H Bone

R Chapurlar

M Brandi

J Brown

E Czerwinski

N Daizadeh

A Grauer

M-A Krieg

S Libanati

Review

For citations:

Papapoulos S., Man Z., Mellstrom D., Radominski S., Reginster J., Resch H., Roman J., Roux S., Cummings S., Bone H., Chapurlar R., Brandi M., Brown J., Czerwinski E., Daizadeh N., Grauer A., Krieg M., Libanati S. Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension. Osteoporosis and Bone Diseases. 2011;14(1):40-40. (In Russ.) https://doi.org/10.14341/osteo2011140-40

JATS XML